A comparative in vitro release study of raloxifene encapsulated ordered MCM-41 and MCM-48 nanoparticles: A dissolution kinetics study in simulated and biorelevant media-Reference-Cited by-同舟云学术

A comparative in vitro release study of raloxifene encapsulated ordered MCM-41 and MCM-48 nanoparticles: A dissolution kinetics study in simulated and biorelevant media

Published:2017-10 Issue: Volume:41 Page:31-44
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Shah Priya V.,Rajput Sadhana J.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference23 articles.

1. Nanocarrier for poorly water-soluble anticancer drugs—barriers of translation and solutions;Narvekar;AAPS PharmSciTech,2014

2. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs;Zhang;Mol. Pharm.,2012

3. Various techniques enhancing bioavailabilty of poorly water soluble drugs;Thakur;J. Drug Deliv. Ther.,2013

4. Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems;Koh;Indian J. Pharm. Sci.,2013

5. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs;Lu;Small,2007

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amino-functionalised mesoporous silica nanoparticles for the delivery of isoniazid and its metal complexes;Materials Chemistry and Physics;2024-10

2. TS‐1@MCM‐48 Core‐Shell Catalysts for Efficient Oxidation of p‐Diethylbenzene to High Value‐Added Derivatives;Chemistry – A European Journal;2024-02-14

3. Synthesis, Evaluation, and Kinetic Studies of Modified Mesoporous Mcm-41 for In-Vitro Controlled Release of Anti-Tubercular Isoniazid and its Complexes;2024

4. Raloxifene's in vitro anticancer effects against MCF-7 cells were facilitated by cholesterol-PEG functionalized mesoporous silica nanoparticles;Journal of Drug Delivery Science and Technology;2023-09

5. In vitro-in vivo correlation in nanocarriers: From protein corona to therapeutic implications;Journal of Controlled Release;2023-02